78 %Between 78% and 88% of patients across Ghana, Kenya, and Nigeria completed tests for hormone receptors and HER2.
Ghana · Kenya · Nigeriacancer du seinobserved 2014 to 2017published 2021BMJ openPubMeddocument of 13 observations
Explore evidence
Gold tier: mechanically validated evidence, with its primary source.
2 evidence items · page 1 / 1
862 patientsHealth records of 862 patients with breast cancer were analysed across six tertiary care institutions in Ghana, Kenya, and Nigeria.
Ghana · Kenya · Nigeriacancer du seinobserved 2014 to 2017published 2021BMJ openPubMeddocument of 13 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.